The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!

References

• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–22. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S, et al. Current and future burden of breast cancer: gGlobal statistics for 2020 and 2040. Breast. 2022;66:15–23. doi:10.1016/j.breast.2022.08.010.
   PubMed Web of Science ®Google Scholar
• Society AC. Breast cancer facts & figures 2019–2020. Am Cancer Soc. 2019;1–44.
   Google Scholar
• Gagnière J, Raisch J, Veziant J, Barnich N, Bonnet R, Buc E, Bringer MA, Pezet D, Bonnet M. Gut microbiota imbalance and colorectal cancer. World J Gastroenterol. 2016;22(2):501–18. doi:10.3748/wjg.v22.i2.501.
   PubMed Web of Science ®Google Scholar
• Laborda-Illanes A, Sanchez-Alcoholado L, Dominguez-Recio MA, Jimenez-Rodriguez B, Lavado R, Comino-Mendez I, Alba E, Queipo-Ortuno MI. Breast and gut microbiota action mechanisms in breast cancer pathogenesis and treatment. Cancers. 2020;12(9):2465. doi:10.3390/cancers12092465.
   PubMed Web of Science ®Google Scholar
• Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer. 2013;13(11):800–812. doi:10.1038/nrc3610.
   PubMed Web of Science ®Google Scholar
• Rahman MM, Islam MR, Shohag S, Ahasan MT, Sarkar N, Khan H, Hasan AM, Cavalu S, Rauf A. Microbiome in cancer: role in carcinogenesis and impact in therapeutic strategies. Biomed Pharmacother. 2022;149:112898. doi:10.1016/j.biopha.2022.112898.
   PubMed Web of Science ®Google Scholar
• Doocey CM, Finn K, Murphy C, Guinane CM. The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development. BMC Microbiol. 2022;22(1):1–17. doi:10.1186/s12866-022-02465-6.
   PubMed Web of Science ®Google Scholar
• Zhou P, Hu Y, Wang X, Shen L, Liao X, Zhu Y, Yu J, Zhao F, Zhou Y, Shen H, et al. Microbiome in cancer: an exploration of carcinogenesis, immune responses and immunotherapy. Front Immunol. 2022;13:877939. doi:10.3389/fimmu.2022.877939.
   PubMed Web of Science ®Google Scholar
• Zyoud SH, Al-Jabi SW, Amer R, Shakhshir M, Shahwan M, Jairoun AA, Akkawi M, Taha AA. Global research trends on the links between the gut microbiome and cancer: a visualization analysis. J Transl Med. 2022;20(1):83. doi:10.1186/s12967-022-03293-y.
   PubMed Web of Science ®Google Scholar
• DiMaio D, Emu B, Goodman AL, Mothes W, Justice A. Cancer Microbiology. JNCI J Nat Cancer Inst. 2022;114(5):651–663. doi:10.1093/jnci/djab212.
   PubMedGoogle Scholar
• Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, Rotter-Maskowitz A, Weiser R, Mallel G, Gigi E, et al. The human tumor microbiome is composed of tumor type–specific intracellular bacteria. Science. 2020;368(6494):973–980. doi:10.1126/science.aay9189.
   PubMed Web of Science ®Google Scholar
• Smith JS, Bosetti C, Muñoz N, Herrero R, Bosch FX, Eluf-Neto J, Meijer CJLM, van den Brule AJC, Franceschi S, Peeling RW. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. International Journal of Cancer. 2004;111(3):431–439. doi:10.1002/ijc.20257.
   PubMed Web of Science ®Google Scholar
• Koshiol J, Wozniak A, Cook P, Adaniel C, Acevedo J, Azócar L, Hsing AW, Roa JC, Pasetti MF, Miquel JF, et al. Salmonella enterica serovar Typhi and gallbladder cancer: a case–control study and meta-analysis. Cancer Med. 2016;5(11):3310–3235. doi:10.1002/cam4.915.
   PubMed Web of Science ®Google Scholar
• Tunsjo HS, Gundersen G, Rangnes F, Noone JC, Endres A, Bemanian V. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients. Eur J Clin Microbiol Infect Dis. 2019;38(7):1367–1376. doi:10.1007/s10096-019-03562-7.
   PubMed Web of Science ®Google Scholar
• Purcell RV, Pearson J, Aitchison A, Dixon L, Frizelle FA, Keenan JI. Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia. PLos One. 2017;12(2):e0171602. doi:10.1371/journal.pone.0171602.
   PubMed Web of Science ®Google Scholar
• Mukherjee AG, Wanjari UR, Bradu P, Murali R, Kannampuzha S, Loganathan T, C GPD, Prakash A, Renu K, Dey A, et al. The crosstalk of the human microbiome in breast and colon cancer: a metabolomics analysis. Crit Rev Oncol Hematol. 2022;176:103757. doi:10.1016/j.critrevonc.2022.103757.
   PubMed Web of Science ®Google Scholar
• Marino MM, Nastri BM, D’Agostino M, Risolo R, De Angelis A, Settembre G, Rienzo M, D’Esposito V, Abbondanza C, Formisano P, et al. Does Gut-breast Microbiota Axis Orchestrates Cancer Progression? Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune. Endocrine & Metabolic Disorders). 2022;22(11):1111–1122. doi:10.2174/1871530322666220331145816.
   Google Scholar
• Ma Z, Qu M, Wang X. Analysis of Gut Microbiota in Patients with Breast Cancer and Benign Breast Lesions. Pol J Microbiol. 2022;71(2):217–226. doi:10.33073/pjm-2022-019.
   PubMed Web of Science ®Google Scholar
• Arnone AA, Cook KL. Gut and breast microbiota as endocrine regulators of hormone receptor-positive breast cancer risk and therapy response. Endocrinology. 2022;164(1):bqac177. doi:10.1210/endocr/bqac177.
   PubMed Web of Science ®Google Scholar
• Minelli EB, Beghini AM, Vesentini S, Marchiori L, Nardo G, Cerutti R, Mortani E. Intestinal microflora as an alternative metabolic source of estrogens in women with uterine leiomyoma and breast cancer. Ann N Y Acad Sci. 1990;595(1):473–479. doi:10.1111/j.1749-6632.1990.tb34337.x.
   Google Scholar
• Zhu J, Liao M, Yao Z, Liang W, Li Q, Liu J, Yang H, Ji Y, Wei W, Tan A, et al. Breast cancer in postmenopausal women is associated with an altered gut metagenome. Microbiome. 2018;6(1):136. doi:10.1186/s40168-018-0515-3.
   PubMed Web of Science ®Google Scholar
• Yang P, Wang Z, Peng Q, Lian W, Chen D. Comparison of the gut microbiota in patients with benign and malignant breast tumors: a pilot study. Evol Bioinform. 2021;17:11769343211057573. doi:10.1177/11769343211057573.
   Web of Science ®Google Scholar
• Bobin-Dubigeon C, Luu HT, Leuillet S, Lavergne SN, Carton T, Vacon FL, Michel C, Nazih H, Bard JM. Faecal microbiota composition varies between patients with breast cancer and healthy women: a comparative case-control study. Nutrients. 2021;13(8):2705. doi:10.3390/nu13082705.
   PubMed Web of Science ®Google Scholar
• Terrisse S, Derosa L, Iebba V, Ghiringhelli F, Vaz-Luis I, Kroemer G, Fidelle M, Christodoulidis S, Segata N, Thomas AM, et al. Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment. Cell Death Differ. 2021;28(9):2778–2796. doi:10.1038/s41418-021-00784-1.
   PubMed Web of Science ®Google Scholar
• Parida S, Sharma D. Microbial Alterations and Risk Factors of Breast Cancer: connections and Mechanistic Insights. Cells. 2020;9(5):1091. doi:10.3390/cells9051091.
   PubMed Web of Science ®Google Scholar
• Ruo SW, Alkayyali T, Win M, Tara A, Joseph C, Kannan A, Srivastava K, Ochuba O, Sandhu JK, Went TR, et al. Role of gut microbiota dysbiosis in breast cancer and novel approaches in prevention, diagnosis, and treatment. Cureus. 2021;13(8):e17472. doi:10.7759/cureus.17472.
   PubMed Web of Science ®Google Scholar
• Konstantinidis T, Tsigalou C, Karvelas A, Stavropoulou E, Voidarou C, Bezirtzoglou E. Effects of antibiotics upon the gut microbiome: a review of the literature. Biomedicines. 2020;8(11):502. doi:10.3390/biomedicines8110502.
   PubMed Web of Science ®Google Scholar
• Wu H, Ganguly S, Tollefsbol TO. Modulating Microbiota as a New Strategy for Breast Cancer Prevention and Treatment. Microorganisms. 2022;10(9):1727. doi:10.3390/microorganisms10091727.
   PubMed Web of Science ®Google Scholar
• McKee AM, Kirkup BM, Madgwick M, Fowler WJ, Price CA, Dreger SA, Ansorge R, Makin KA, Caim S, Le Gall G, et al. Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth. Iscience. 2021;24(9):103012. doi:10.1016/j.isci.2021.103012.
   PubMed Web of Science ®Google Scholar
• Plaza-Díaz J, Álvarez-Mercado AI, Ruiz-Marín CM, Reina-Pérez I, Pérez-Alonso AJ, Sánchez-Andujar MB, Torné P, Gallart-Aragón T, Sánchez-Barrón MT, Reyes Lartategui S, et al. Association of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical study. BMC Cancer. 2019;19(1):495. doi:10.1186/s12885-019-5660-y.
   PubMedGoogle Scholar
• Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330–337. doi:10.1038/nature11252.
   PubMed Web of Science ®Google Scholar
• Flores R, Shi J, Fuhrman B, Xu X, Veenstra TD, Gail MH, Gajer P, Ravel J, Goedert JJ. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med. 2012;10(1):253. doi:10.1186/1479-5876-10-253.
   PubMedGoogle Scholar
• Fuhrman BJ, Feigelson HS, Flores R, Gail MH, Xu X, Ravel J, Goedert JJ. Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women. J Clin Endocr Metab. 2014;99(12):4632–4640. doi:10.1210/jc.2014-2222.
   PubMed Web of Science ®Google Scholar
• Ervin SM, Li H, Lim L, Roberts LR, Liang X, Mani S, Redinbo MR. Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens. J Biol Chem. 2019;294(49):18586–18599. doi:10.1074/jbc.RA119.010950.
   PubMed Web of Science ®Google Scholar
• Chan AA, Bashir M, Rivas MN, Duvall K, Sieling PA, Pieber TR, Vaishampayan PA, Love SM, Lee DJ. Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors. Sci Rep. 2016;6(1):28061. doi:10.1038/srep28061.
   PubMedGoogle Scholar
• Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PHM, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw K-T, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer. 2005;12(4):1071–1082. doi:10.1677/erc.1.01038.
   PubMed Web of Science ®Google Scholar
• Plottel CS, Blaser MJ. Microbiome and malignancy. Cell Host Microbe. 2011;10(4):324–335. doi:10.1016/j.chom.2011.10.003.
   PubMed Web of Science ®Google Scholar
• Kwa M, Plottel CS, Blaser MJ, Adams S. The intestinal microbiome and estrogen receptor–positive female breast cancer. J Natl Cancer Inst. 2016; 108(8):djw029.
   PubMedGoogle Scholar
• Goedert JJ, Jones G, Hua X, Xu X, Yu G, Flores R, Falk RT, Gail MH, Shi J, Ravel J, et al. Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. J Natl Cancer Inst. 2015;107(8):djv147. doi:10.1093/jnci/djv147.
   PubMedGoogle Scholar
• Aarnoutse R, Hillege LE, Ziemons J, De Vos-Geelen J, de Boer M, Aerts EMER, Vriens BEPJ, van Riet Y, Vincent J, van de Wouw AJ, et al. Intestinal Microbiota in Postmenopausal Breast Cancer Patients and Controls. Cancers. 2021;13(24):6200. doi:10.3390/cancers13246200.
   PubMed Web of Science ®Google Scholar
• Okubo R, Kinoshita T, Katsumata N, Uezono Y, Xiao J, Matsuoka YJ. Impact of chemotherapy on the association between fear of cancer recurrence and the gut microbiota in breast cancer survivors. Brain Behav Immun. 2020;85:186–191. doi:10.1016/j.bbi.2019.02.025.
   PubMed Web of Science ®Google Scholar
• Ingman WV. The gut microbiome: a new player in breast cancer metastasis. Cancer Res. 2019;79(14):3539–3541. doi:10.1158/0008-5472.CAN-19-1698.
   PubMed Web of Science ®Google Scholar
• Parida S, Wu S, Siddharth S, Wang G, Muniraj N, Nagalingam A, Hum C, Mistriotis P, Hao H, Talbot CC, et al. A Procarcinogenic Colon Microbe Promotes Breast Tumorigenesis and Metastatic Progression and Concomitantly Activates Notch and β-Catenin AxesETBF Promotes Breast Carcinogenesis. Cancer Discov. 2021;11(5):1138–1157. doi:10.1158/2159-8290.CD-20-0537.
   PubMed Web of Science ®Google Scholar
• Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, Fainsod-Levi T, Yajuk O, Isaacson B, Abed J, Maalouf N, et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat Commun. 2020;11(1):3259. doi:10.1038/s41467-020-16967-2.
   PubMed Web of Science ®Google Scholar
• Fu A, Yao B, Dong T, Chen Y, Yao J, Liu Y, Li H, Bai H, Liu X, Zhang Y, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. 2022;185(8):1356–1372.e26. doi:10.1016/j.cell.2022.02.027.
   PubMed Web of Science ®Google Scholar
• Bard JM, Luu HT, Dravet F, Michel C, Moyon T, Pagniez A, Nazih H, Bobin‐Dubigeon C. Relationship between intestinal microbiota and clinical characteristics of patients with early stage breast cancer. FASEB Journal. 2015;29(S1):914.2. doi:10.1096/fasebj.29.1_supplement.914.2.
   Google Scholar
• Luu TH, Michel C, Bard J-M, Dravet F, Nazih H, Bobin-Dubigeon C. Intestinal proportion of Blautia sp. is associated with clinical stage and histoprognostic grade in patients with early-stage breast cancer. Nutr Cancer. 2017;69(2):267–275. doi:10.1080/01635581.2017.1263750.
   PubMed Web of Science ®Google Scholar
• Fernández MF, Reina-Pérez I, Astorga J, Rodríguez-Carrillo A, Plaza-Díaz J, Fontana L. Breast cancer and its relationship with the microbiota. Int J Env Res Pub He. 2018;15(8):1747. doi:10.3390/ijerph15081747.
   PubMed Web of Science ®Google Scholar
• Pierobon M, Frankenfeld CL. Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;137(1):307–314. doi:10.1007/s10549-012-2339-3.
   PubMed Web of Science ®Google Scholar
• John GK, Mullin GE. The gut microbiome and obesity. Curr Oncol Rep. 2016;18(7):45. doi:10.1007/s11912-016-0528-7.
   PubMed Web of Science ®Google Scholar
• Hossain F, Majumder S, David J, Bunnell BA, Miele L. Obesity modulates the gut microbiome in triple-negative breast cancer. Nutrients. 2021;13(10):3656. doi:10.3390/nu13103656.
   PubMed Web of Science ®Google Scholar
• Ransohoff JD, Ritter V, Purington N, Andrade K, Han S, Liu M, Liang S-Y, John EM, Gomez SL, Telli ML, et al. Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer. Nat Commun. 2023;14(1):2053. doi:10.1038/s41467-023-37636-0.
   PubMed Web of Science ®Google Scholar
• Paulsen JA, Ptacek TS, Carter SJ, Liu N, Kumar R, Hyndman L, Lefkowitz EJ, Morrow CD, Rogers LQ. Gut microbiota composition associated with alterations in cardiorespiratory fitness and psychosocial outcomes among breast cancer survivors. Support Care Cancer. 2017;25(5):1563–1570. doi:10.1007/s00520-016-3568-5.
   PubMed Web of Science ®Google Scholar
• De Spiegeleer B, Verbeke F, D’Hondt M, Hendrix A, Van De Wiele C, Burvenich C, Peremans K, De Wever O, Bracke M, Wynendaele E, et al. The quorum sensing peptides PhrG, CSP and EDF promote angiogenesis and invasion of breast cancer cells in vitro. PLoS One. 2015;10(3):e0119471. doi:10.1371/journal.pone.0119471.
   PubMed Web of Science ®Google Scholar
• Lakritz JR, Poutahidis T, Mirabal S, Varian BJ, Levkovich T, Ibrahim YM, Ward JM, Teng EC, Fisher B, Parry N, et al. Gut bacteria require neutrophils to promote mammary tumorigenesis. Oncotarget. 2015;6(11):9387–96. doi:10.18632/oncotarget.3328.
   PubMedGoogle Scholar
• Makhoul I. The gut microbiome and gastrointestinal toxicities as determinants of the response to neoadjuvant chemotherapies for advanced breast cancer IRB# 204897 Version: 5 NCT02696759. Jun 07 2019.
   Google Scholar
• Buchta Rosean C, Bostic RR, Ferey JCM, Feng T-Y, Azar FN, Tung KS, Dozmorov MG, Smirnova E, Bos PD, Rutkowski MR Preexisting Commensal Dysbiosis is a Host-Intrinsic Regulator of Tissue Inflammation and Tumor Cell Dissemination in Hormone Receptor–Positive Breast CancerDysbiosis Enhances Dissemination of HR+ Breast Cancer. Cancer Res. 2019;79(14):3662–3675. doi:10.1158/0008-5472.CAN-18-3464.
   PubMed Web of Science ®Google Scholar
• Oelschlaeger TA, Tall BD. Invasion of cultured human epithelial cells by Klebsiella pneumoniae isolated from the urinary tract. Infect Immun. 1997;65(7):2950–2958. doi:10.1128/iai.65.7.2950-2958.1997.
   PubMed Web of Science ®Google Scholar
• Yao Z-W, Yang X, Zhao B-C, Deng F, Jiang Y-M, Pan W-Y, Chen X-D, Zhou B-W, Zhang W-J, Hu J-J, et al. Predictive and preventive potential of preoperative gut microbiota in chronic postoperative pain in breast cancer survivors. Anesth Analg. 2022;134(4):699–709. doi:10.1213/ANE.0000000000005713.
   PubMed Web of Science ®Google Scholar
• Alexander JL, Wilson ID, Teare J, Marchesi JR, Nicholson JK, Kinross JM. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastro Hepat. 2017;14(6):356–365. doi:10.1038/nrgastro.2017.20.
   PubMed Web of Science ®Google Scholar
• Horigome A, Okubo R, Hamazaki K, Kinoshita T, Katsumata N, Uezono Y, Xiao JZ, Matsuoka YJ. Association between blood omega-3 polyunsaturated fatty acids and the gut microbiota among breast cancer survivors. Benef Microbes. 2019;10(7):751–758. doi:10.3920/BM2019.0034.
   PubMed Web of Science ®Google Scholar
• Viaud S, Daillère R, Boneca IG, Lepage P, Langella P, Chamaillard M, Pittet MJ, Ghiringhelli F, Trinchieri G, Goldszmid R, et al. Gut microbiome and anticancer immune response: really hot Sh* t! Cell Death Differ. 2015;22(2):199–214. doi:10.1038/cdd.2014.56.
   PubMed Web of Science ®Google Scholar
• Sampsell K, Hao D, Reimer RA. The gut microbiota: a potential gateway to improved health outcomes in breast cancer treatment and survivorship. Int J Mol Sci. 2020;21(23):9239. doi:10.3390/ijms21239239.
   PubMed Web of Science ®Google Scholar
• Guan X, Ma F, Sun X, Li C, Li L, Liang F, Li S, Yi Z, Liu B, Xu B. Gut microbiota profiling in patients with HER2-negative metastatic breast cancer receiving metronomic chemotherapy of capecitabine compared to those under conventional dosage. Front Oncol. 2020;10:902. doi:10.3389/fonc.2020.00902.
   PubMed Web of Science ®Google Scholar
• Hinshaw DC, Swain CA, Chen D, Hanna A, Molina PA, Maynard CL, Lee G, McFarland BC, Samant RS, Shevde LA. Hedgehog blockade remodels the gut microbiota and the intestinal effector CD8+ T cells in a mouse model of mammary carcinoma. Lab Invest. 2022;102(11):1236–1244. doi:10.1038/s41374-022-00828-1.
   PubMed Web of Science ®Google Scholar
• Yue B, Gao R, Wang Z, Dou W. Microbiota-Host-Irinotecan Axis: a New Insight Toward Irinotecan Chemotherapy. Front Cell Infect Microbiol. 2021;11:710945. doi:10.3389/fcimb.2021.710945.
   PubMed Web of Science ®Google Scholar
• Haiser HJ, Turnbaugh PJ. Developing a metagenomic view of xenobiotic metabolism. Pharmacol Res. 2013;69(1):21–31. doi:10.1016/j.phrs.2012.07.009.
   PubMed Web of Science ®Google Scholar
• Chiba A, Bawaneh A, Velazquez C, Clear KYJ, Wilson AS, Howard-McNatt M, Levine EA, Levi-Polyachenko N, Yates-Alston SA, Diggle SP, et al. Neoadjuvant chemotherapy shifts breast tumor microbiota populations to regulate drug responsiveness and the development of metastasis. Mol Cancer Res. 2020;18(1):130–139. doi:10.1158/1541-7786.MCR-19-0451.
   PubMed Web of Science ®Google Scholar
• Salva S, Marranzino G, Villena J, Agüero G, Alvarez S. Probiotic Lactobacillus strains protect against myelosuppression and immunosuppression in cyclophosphamide-treated mice. Int Immunopharmacol. 2014;22(1):209–221. doi:10.1016/j.intimp.2014.06.017.
   PubMed Web of Science ®Google Scholar
• Westman EL, Canova MJ, Radhi IJ, Koteva K, Kireeva I, Waglechner N, Wright GD. Bacterial inactivation of the anticancer drug doxorubicin. Chem Biol. 2012;19(10):1255–1264. doi:10.1016/j.chembiol.2012.08.011.
   PubMed Web of Science ®Google Scholar
• Mikó E, Kovács T, Sebő É, Tóth J, Csonka T, Ujlaki G, Sipos A, Szabó J, Méhes G, Bai P. Microbiome—microbial metabolome—cancer cell interactions in breast cancer—familiar, but unexplored. Cells. 2019;8(4):293. doi:10.3390/cells8040293.
   PubMedGoogle Scholar
• Parida S, Sharma D. The power of small changes: comprehensive analyses of microbial dysbiosis in breast cancer. Biochimica Et Biophysica Acta (BBA) - Reviews On Cancer. 2019;1871(2):392–405. doi:10.1016/j.bbcan.2019.04.001.
   PubMed Web of Science ®Google Scholar
• Li Y, Dong B, Wu W, Wang J, Jin H, Chen K, Huang K, Huang S, Yao Y. Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients. Front Oncol. 2022;12:865121. doi:10.3389/fonc.2022.865121.
   PubMed Web of Science ®Google Scholar
• Bawaneh A, Wilson AS, Levi N, Howard-McNatt MM, Chiba A, Soto-Pantoja DR, Cook KL. Intestinal microbiota influence doxorubicin responsiveness in triple-negative breast cancer. Cancers. 2022;14(19):4849. doi:10.3390/cancers14194849.
   PubMed Web of Science ®Google Scholar
• Vernaci G, Savarino EV, Patuzzi I, Facchin S, Zingone F, Massa D, Faggioni G, Giarratano T, Miglietta F, Griguolo G, et al. Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy. Oncologist. 2023:oyad060. doi:10.1093/oncolo/oyad060
   PubMed Web of Science ®Google Scholar
• McLaughlin MM, Dacquisto MP, Jacobus DP, Horowitz RE. Effects of the germfree state on responses of mice to whole-body irradiation. Radiat Res. 1964;23(3):333–349. doi:10.2307/3571614.
   PubMed Web of Science ®Google Scholar
• Cui M, Xiao H, Li Y, Zhou L, Zhao S, Luo D, Zheng Q, Dong J, Zhao Y, Zhang X, et al. Faecal microbiota transplantation protects against radiation‐induced toxicity. EMBO Mol Med. 2017;9(4):448–461. doi:10.15252/emmm.201606932.
   PubMed Web of Science ®Google Scholar
• McGee HM, Jiang D, Soto-Pantoja DR, Nevler A, Giaccia AJ, Woodward WA. Targeting the Tumor Microenvironment in Radiation Oncology: proceedings from the 2018 ASTRO–AACR Research WorkshopProceedings of ASTRO–AACR Workshop on Radiation and the TME. Clin Cancer Res. 2019;25(10):2969–2974. doi:10.1158/1078-0432.CCR-18-3781.
   PubMed Web of Science ®Google Scholar
• Rahal OM, Wolfe AR, Mandal PK, Larson R, Tin S, Jimenez C, Zhang D, Horton J, Reuben JM, McMurray JS, et al.Blocking interleukin (IL) 4-and IL13-mediated phosphorylation of STAT6 (Tyr641) decreases M2 polarization of macrophages and protects against macrophage-mediated radioresistance of inflammatory breast cancer. International Journal of Radiation Oncology* Biology* Physics, 2018;100(4):1034–1043Int J Radiat Oncol10.1016/j.ijrobp.2017.11.043
   PubMed Web of Science ®Google Scholar
• van Vliet MJ, Harmsen HJM, de Bont ESJM, Tissing WJE. The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog. 2010;6(5):e1000879. doi:10.1371/journal.ppat.1000879.
   PubMed Web of Science ®Google Scholar
• Routy B, Gopalakrishnan V, Daillère R, Zitvogel L, Wargo JA, Kroemer G. The gut microbiota influences anticancer immunosurveillance and general health. Nat Rev Clin Oncol. 2018;15(6):382–396. doi:10.1038/s41571-018-0006-2.
   PubMed Web of Science ®Google Scholar
• Cai Z, Sanchez A, Shi Z, Zhang T, Liu M, Zhang D. Activation of Toll-like Receptor 5 on Breast Cancer Cells by Flagellin Suppresses Cell Proliferation and Tumor GrowthAntitumor Activity of TLR5 Signaling in Breast Cancer Cells. Cancer Res. 2011;71(7):2466–2475. doi:10.1158/0008-5472.CAN-10-1993.
   PubMed Web of Science ®Google Scholar
• Zhang J, Xia Y, Sun J. Breast and gut microbiome in health and cancer. Genes & Diseases. 2021;8(5):581–589. doi:10.1016/j.gendis.2020.08.002.
   PubMed Web of Science ®Google Scholar
• Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Man Lei Y, Jabri B, Alegre M-L, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy. Science. 2015;350(6264):1084–1089. doi:10.1126/science.aac4255.
   PubMed Web of Science ®Google Scholar
• Elkrief A, Derosa L, Zitvogel L, Kroemer G, Routy B. The intimate relationship between gut microbiota and cancer immunotherapy. Gut Microbes. 2019;10(3):424–428. doi:10.1080/19490976.2018.1527167.
   PubMed Web of Science ®Google Scholar
• Vivarelli S, Salemi R, Candido S, Falzone L, Santagati M, Stefani S, Torino F, Banna GL, Tonini G, Libra M, et al. Gut microbiota and cancer: from pathogenesis to therapy. Cancers. 2019;11(1):38. doi:10.3390/cancers11010038.
   PubMed Web of Science ®Google Scholar
• Vétizou M, Pitt JM, Daillère R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CPM, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350(6264):1079–1084. doi:10.1126/science.aad1329.
   PubMed Web of Science ®Google Scholar
• Vitorino M, Baptista de Almeida S, Alpuim Costa D, Faria A, Calhau C, Azambuja Braga S. Human Microbiota and Immunotherapy in Breast Cancer-A Review of Recent Developments. Front Oncol. 2021;11:11. doi:10.3389/fonc.2021.815772.
   Web of Science ®Google Scholar
• Maroof H, Hassan ZM, Mobarez AM, Mohamadabadi MA. Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J Clin Immunol. 2012;32(6):1353–1359. doi:10.1007/s10875-012-9708-x.
   PubMed Web of Science ®Google Scholar
• Di Modica M, Gargari G, Regondi V, Bonizzi A, Arioli S, Belmonte B, De Cecco L, Fasano E, Bianchi F, Bertolotti A, et al. Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast CancerImplication of Gut Microbes in Response to Trastuzumab Therapy. Cancer Res. 2021;81(8):2195–2206. doi:10.1158/0008-5472.CAN-20-1659.
   PubMed Web of Science ®Google Scholar
• Kovács T, Mikó E, Vida A, Sebő É, Toth J, Csonka T, Boratkó A, Ujlaki G, Lente G, Kovács P, et al. Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors. Sci Rep. 2019;9(1):1–14. doi:10.1038/s41598-018-37664-7.
   PubMedGoogle Scholar
• Kovács T, Mikó E, Ujlaki G, Yousef H, Csontos V, Uray K, Bai P. The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer. Cancer Metastasis Rev. 2021;40(4):1223–1249. doi:10.1007/s10555-021-10013-3.
   PubMed Web of Science ®Google Scholar
• Mikó E, Vida A, Kovács T, Ujlaki G, Trencsényi G, Márton J, Sári Z, Kovács P, Boratkó A, Hujber Z, et al. Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness. Biochimica et Biophysica Acta (BBA)-Bioenergetics. 2018;1859(9):958–974. doi:10.1016/j.bbabio.2018.04.002.
   PubMed Web of Science ®Google Scholar
• Salimi V, Shahsavari Z, Safizadeh B, Hosseini A, Khademian N, Tavakoli-Yaraki M. Sodium butyrate promotes apoptosis in breast cancer cells through reactive oxygen species (ROS) formation and mitochondrial impairment. Lipids Health Dis. 2017;16(1):1–11. doi:10.1186/s12944-017-0593-4.
   PubMedGoogle Scholar
• Thirunavukkarasan M, Wang C, Rao A, Hind T, Teo YR, Siddiquee AAM, Goghari MAI, Kumar AP, Herr DR. Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells. PLoS One. 2017;12(10):e0186334. doi:10.1371/journal.pone.0186334.
   PubMed Web of Science ®Google Scholar
• Park H-S, Han J-H, Park JW, Lee D-H, Jang K-W, Lee M, Heo K-S, Myung C-S. Sodium propionate exerts anticancer effect in mice bearing breast cancer cell xenograft by regulating JAK2/STAT3/ROS/p38 MAPK signaling. Acta Pharmacol Sin. 2021;42(8):1311–1323. doi:10.1038/s41401-020-00522-2.
   PubMed Web of Science ®Google Scholar
• Garmpis N, Damaskos C, Garmpi A, Kalampokas E, Kalampokas T, Spartalis E, Daskalopoulou A, Valsami S, Kontos M, Nonni A, et al. Histone deacetylases as new therapeutic targets in triple-negative breast cancer: progress and promises. Cancer Genomics Proteomics. 2017;14(5):299–313. doi:10.21873/cgp.20041.
   PubMed Web of Science ®Google Scholar
• Avand A, Akbari V, Shafizadegan S. In vitro cytotoxic activity of a Lactococcus lactis antimicrobial peptide against breast cancer cells. Iranian Journal Of Biotechnology. 2018;16(3):213–220. doi:10.21859/ijb.1867.
   Web of Science ®Google Scholar
• Eslami-S Z, Majidzadeh-A K, Halvaei S, Babapirali F, Esmaeili R. Microbiome and breast cancer: new role for an ancient population. Front Oncol. 2020;10:120. doi:10.3389/fonc.2020.00120.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay I, Nandi D, Nag A. The pint-sized powerhouse: illuminating the mighty role of the gut microbiome in improving the outcome of anti-cancer therapy. Semin Cancer Biol. 2021;70:98–111. doi:10.1016/j.semcancer.2020.07.012.
   PubMed Web of Science ®Google Scholar
• De Leblanc ADM, Matar C, Thériault C, Perdigón G. Effects of milk fermented by Lactobacillus helveticus R389 on immune cells associated to mammary glands in normal and a breast cancer model. Immunobiology. 2005;210(5):349–358. doi:10.1016/j.imbio.2005.05.024.
   PubMed Web of Science ®Google Scholar
• Parida S, Sharma D. Microbial alterations and risk factors of breast cancer: connections and mechanistic insights. Cells. 2020;9(5):1091. doi:10.3390/cells9051091.
   PubMed Web of Science ®Google Scholar
• Yazdi MH, Soltan Dallal MM, Hassan ZM, Holakuyee M, Agha Amiri S, Abolhassani M, Mahdavi M. Oral administration of Lactobacillus acidophilus induces IL-12 production in spleen cell culture of BALB/c mice bearing transplanted breast tumour. Br J Nutr. 2010;104(2):227–232. doi:10.1017/S0007114510000516.
   PubMed Web of Science ®Google Scholar
• Fooladi AAI, Yazdi MH, Pourmand MR, Mirshafiey A, Mohammad Hassan Z, Azizi T, Mahdavi M, Soltan Dallal MM. Th1 cytokine production induced by Lactobacillus acidophilus in BALB/c mice bearing transplanted breast tumor. Jundishapur Journal Of Microbiology. 2015;8(4):e17354. doi:10.5812/jjm.8(4)2015.17354.
   PubMed Web of Science ®Google Scholar
• Lakritz JR, Poutahidis T, Levkovich T, Varian BJ, Ibrahim YM, Chatzigiagkos A, Mirabal S, Alm EJ, Erdman SE. Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice. International Journal Of Cancer. 2014;135(3):529–540. doi:10.1002/ijc.28702.
   PubMed Web of Science ®Google Scholar
• Kassayova M, Bobrov N, Strojný L, Kisková T, Mikeš J, Demečková V, Orendáš P, Bojková B, Péč M, Kubatka P, et al. Preventive effects of probiotic bacteria Lactobacillus plantarum and dietary fiber in chemically-induced mammary carcinogenesis. Anticancer Res. 2014;34(9):4969–4975.
   PubMed Web of Science ®Google Scholar
• Ma J, Sun L, Liu Y, Ren H, Shen Y, Bi F, Zhang T, Wang X. Alter between gut bacteria and blood metabolites and the anti-tumor effects of Faecalibacterium prausnitzii in breast cancer. BMC Microbiol. 2020;20(1):82. doi:10.1186/s12866-020-01739-1.
   PubMed Web of Science ®Google Scholar
• Johnson DE, O’Keefe RA, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234–248. doi:10.1038/nrclinonc.2018.8.
   PubMed Web of Science ®Google Scholar
• Hassan Z, Mustafa S, Rahim RA, Isa NM. Anti-breast cancer effects of live, heat-killed and cytoplasmic fractions of Enterococcus faecalis and Staphylococcus hominis isolated from human breast milk. In Vitro Cell Dev Biol Anim. 2016;52(3):337–348. doi:10.1007/s11626-015-9978-8.
   PubMed Web of Science ®Google Scholar
• Juan Z, Qing Z, Yongping L, Qian L, Wu W, Wen Y, Tong J, Ding B. Probiotics for the Treatment of Docetaxel-Related Weight Gain of Breast Cancer Patients—A Single-Center, Randomized, Double-Blind, and Placebo-Controlled Trial. Frontiers in nutrition. 2021;8:762929. doi:10.3389/fnut.2021.762929.
   PubMedGoogle Scholar
• Sampsell K, Wang W, Ohland C, Mager LF, Pett N, Lowry DE, Sales KM, McNeely ML, McCoy KD, Culos-Reed SN, et al. Exercise and Prebiotic Fiber Provide Gut Microbiota-Driven Benefit in a Survivor to Germ-Free Mouse Translational Model of Breast Cancer. Cancers. 2022;14(11):2722. doi:10.3390/cancers14112722.
   PubMed Web of Science ®Google Scholar
• Serban DE. Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics. Cancer Lett. 2014;345(2):258–270. doi:10.1016/j.canlet.2013.08.013.
   PubMed Web of Science ®Google Scholar
• Gilani GS, Anderson JJB. Phytoestrogens and Health. 1st Ed. New York: The American Oil Chemists Society; 2002. doi:10.1201/9781003040453.
   Google Scholar
• Toi M, Hirota S, Tomotaki A, Sato N, Hozumi Y, Anan K, Nagashima T, Tokuda Y, Masuda N, Ohsumi S, et al. Probiotic beverage with soy isoflavone consumption for breast cancer prevention: a case-control study. Curr Nutr Food Sci. 2013;9(3):194–200. doi:10.2174/15734013113099990001.
   PubMedGoogle Scholar
• Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Risk factors for breast cancer by age and menopausal status: acase-control study in Singapore. Cancer Causes Control. 1992;3(4):313–322.
   PubMed Web of Science ®Google Scholar
• Hirose K, Imaeda N, Tokudome Y, Goto C, Wakai K, Matsuo K, Ito H, Toyama T, Iwata H, Tokudome S, et al. Soybean products and reduction of breast cancer risk: a case–control study in Japan. Br J Cancer. 2005;93(1):15–22. doi:10.1038/sj.bjc.6602659.
   PubMed Web of Science ®Google Scholar
• Wu AH, Ziegler RG, Horn-Ross PL, Nomura AM, West DW, Kolonel LN, Rosenthal JF, Hoover RN, Pike MC. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers & Prev.1996;5(11):901–906.
   PubMed Web of Science ®Google Scholar
• Dai Q, Shu X-O, Jin F, Potter JD, Kushi LH, Teas J, Gao Y-T, Zheng W. Population-based case–control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer. 2001;85(3):372–378. doi:10.1054/bjoc.2001.1873.
   PubMed Web of Science ®Google Scholar
• Wu AH, Wan P, Hankin J, Tseng C-C, Yu MC, Pike MC. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans Carcinogenesis. 2002;23(9):1491–1496. doi:10.1093/carcin/23.9.1491.
   PubMed Web of Science ®Google Scholar
• Wu AH, Yu MC, Tseng C-C, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer. 2008;98(1):9–14. doi:10.1038/sj.bjc.6604145.
   PubMed Web of Science ®Google Scholar
• Bhatt AP, Redinbo MR, Bultman SJ. The role of the microbiome in cancer development and therapy. CA Cancer J Clin. 2017;67(4):326–344. doi:10.3322/caac.21398.
   PubMed Web of Science ®Google Scholar
• Lehouritis P, Cummins J, Stanton M, Murphy CT, McCarthy FO, Reid G, Urbaniak C, Byrne WL, Tangney M. Local bacteria affect the efficacy of chemotherapeutic drugs. Sci Rep. 2015;5(1):14554. doi:10.1038/srep14554.
   PubMed Web of Science ®Google Scholar
• Shi L, Sheng J, Wang M, Luo H, Zhu J, Zhang B, Liu Z, Yang X. Combination therapy of TGF-β blockade and commensal-derived probiotics provides enhanced antitumor immune response and tumor suppression. Theranostics. 2019;9(14):4115–4129. doi:10.7150/thno.35131.
   PubMed Web of Science ®Google Scholar
• Chen J, Douglass J, Prasath V, Neace M, Atrchian S, Manjili MH, Shokouhi S, Habibi M. The microbiome and breast cancer: a review. Breast Cancer Res Treat. 2019;178(3):493–496. doi:10.1007/s10549-019-05407-5.
   PubMed Web of Science ®Google Scholar
• Suzuki R, Rylander-Rudqvist T, Ye W, Saji S, Adlercreutz H, Wolk A. Dietary fiber intake and risk of postmenopausal breast cancer defined by estrogen and progesterone receptor status—a prospective cohort study among Swedish women. International Journal Of Cancer. 2008;122(2):403–412. doi:10.1002/ijc.23060.
   PubMed Web of Science ®Google Scholar
• Zengul AG, Demark-Wahnefried W, Barnes S, Morrow CD, Bertrand B, Berryhill TF, Frugé AD. Associations between dietary fiber, the fecal microbiota and estrogen metabolism in postmenopausal women with breast cancer. Nutr Cancer. 2021;73(7):1108–1117. doi:10.1080/01635581.2020.1784444.
   PubMed Web of Science ®Google Scholar
• Sinha A, Li Y, Mirzaei MK, Shamash M, Samadfam R, King IL, Maurice CF. Transplantation of bacteriophages from ulcerative colitis patients shifts the gut bacteriome and exacerbates the severity of DSS colitis. Microbiome. 2022;10(1):105. doi:10.1186/s40168-022-01275-2.
   PubMed Web of Science ®Google Scholar
• Wu D, Zhang C, Liu Y, Yao J, Yang X, Wu S, Du J, Yang X. Beyond faecal microbiota transplantation, the non-negligible role of faecal virome or bacteriophage transplantation. J Microbiol Immunol Infect. 2023;S1684–1182(23):00042–7. doi:10.1016/j.jmii.2023.02.005.
   Google Scholar
• Kabwe M, Meehan-Andrews T, Ku H, Petrovski S, Batinovic S, Chan HT, Tucci J. Lytic Bacteriophage EFA1 Modulates HCT116 Colon Cancer Cell Growth and Upregulates ROS Production in an Enterococcus faecalis Co-culture System. Front Microbiol. 2021;12:650849. doi:10.3389/fmicb.2021.650849.
   PubMed Web of Science ®Google Scholar
• Yin XR, Liu P, Xu X, Xia Y, Huang K-Z, Wang Q-D, Lai M-M, Yu Q-G, Zheng X-Q. Elevated plasma phage load as a marker for intestinal permeability in leukemic patients. Med Microbiol Immunol. 2020;209(6):693–703. doi:10.1007/s00430-020-00694-y.
   PubMed Web of Science ®Google Scholar
• Dong X, Pan P, Zheng D-W, Bao P, Zeng X, Zhang X-Z. Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer. Sci Adv. 2020;6(20):eaba1590. doi:10.1126/sciadv.aba1590.
   PubMed Web of Science ®Google Scholar
• Zheng DW, Dong X, Pan P, Chen K-W, Fan J-X, Cheng S-X, Zhang X-Z. Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy. Nat Biomed Eng. 2019;3(9):717–728. doi:10.1038/s41551-019-0423-2.
   PubMed Web of Science ®Google Scholar